Kapağı yeniden konumlandırmak için sürükleyin
@willirosellini
Yaklaşık
Will Rosellini is the President of CytoImmune Therapeutics, a clinical stage biotechnology company. Previously, he was Chief Executive Officer of Perimeter Medical and, prior to that, Chief Executive Officer of Nexeon Medsystems, a medical device manufacturing company that went public in 2017.
Aşağıdaki
(18)
İzleyiciler
(5)
Avatarını kırp
